Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee

Stefan Siebert, MD

University of Glasgow
Glasgow, United Kingdom

Professor of Inflammation Medicine and Rheumatology. Clinically active.

Presentation(s):

  • 1460: Effect of Guselkumab and IL-17 Inhibitors on Work Productivity and Activity Impairment in Psoriatic Arthritis: 6-Month Results of the PsABIOnd Observational Study

    Monday, October 27, 2025
    10:30 AM - 12:30 PM Central Time

    Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Terminated); Amgen: Advisor or Review Panel Member (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); AstraZeneca: Advisor or Review Panel Member (Terminated); Eli Lilly: Grant/Research Support (Ongoing); GlaxoSmithKlein(GSK): Grant/Research Support (Terminated); Janssen: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Pfizer: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Syncona: Advisor or Review Panel Member (Terminated); Teijin Pharma: Advisor or Review Panel Member (Terminated); UCB: Advisor or Review Panel Member (Terminated), Grant/Research Support (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)